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Integral membrane transporters play essential roles in the movement of
substrates across biological membranes. One approach to produce trans-
porters suitable for structural studies is to introduce mutations that reduce
conformational flexibility and increase stability. However, it can be difficult
to predict which mutations will result in a more stable protein. Previously,
we stabilised the uric acid-xanthine transporter, UapA, a member of the
SLC23 family, through introduction of a single-point mutation, G411V,
trapping the protein in the inward-facing conformation. Here, we
attempted to stabilise the structurally related BOR1 transporter from Ara-
bidopsis thaliana, a member of the SLC4 family, by introducing the equiva-
lent substitution. We identified possible residues, P362 and M363, in
AtBOR1, likely to be equivalent to the G411 of UapA, and generated four
mutants, P362V or L and M363F or Y. Stability analysis using heated Flu-
orescent Size Exclusion Chromatography indicated that the M363F/Y
mutants were more stable than the WT AtBOR1 and P362V/L mutants.
Furthermore, functional complementation analysis revealed that the
M363F/Y mutants exhibited reduced transport activity compared to the
P362V/L and WT proteins. Purification and crystallisation of the M363F/
Y proteins yielded crystals that diffracted better than WT (5.5 vs 7 A). We
hypothesise that the increased bulk of the F and Y substitutions limits the
ability of the protein to undergo the conformational rearrangements associ-
ated with transport. These proteins represent a basis for future studies on
AtBOR1.
Secondary active transporters are essential mediators
of cellular uptake and export. They transport a wide
range of substrates which bind to substrate-specific
binding sites on one side of the membrane. Upon
binding of both the substrate and the cotransported
ion, the transporter undergoes a series of major con-
formational rearrangements to both close access on
the substrate-binding side of the membrane and open
access on the opposite side of the membrane [1].
Understanding of precisely how transporters perform
their function has greatly increased in the last decade
due to a substantial number of high-resolution crystal-
lographic structures [2]. However, we still lack a
detailed understanding of the mechanism of many
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transporters, particularly those from eukaryotic
sources. A key difficulty associated with structural
studies of integral membrane transporters relates to
their conformationally dynamic nature, associated with
a lack of stability particularly in the detergent-based
solutions required for membrane extraction, isolation
and crystallisation. Researchers have employed a num-
ber of approaches to limit protein flexibility and trap
transporters into single conformational states, includ-
ing the use of inhibitors [3], antibodies or nanobodies
[4] and introduction of mutations [5,6]. Often combi-
nations of these approaches are used; Fab fragment
and mutations [7], mutations and an alternative sub-
strate [8,9], mutagenesis and a chimera of two trans-
porters [10].
Our group solved the structure of the H+-dependent
uric acid-xanthine transporter, UapA from the model
organism, Aspergillus nidulans [11] in the inward-facing
conformation. In the case of UapA, the wild-type
(WT) form of the protein expressed well and could be
isolated to high homogeneity [12]. However, the iso-
lated WT protein was relatively unstable, undergoing
degradation at both 20 and 4 °C [13]. Based on previ-
ous studies on UapA, six single-point mutations were
identified which retained the ability to traffic to the
membrane in A. nidulans but were no longer transport
active [14,15]. These features indicated that the
mutants were correctly folded but might be conforma-
tionally restricted. Screening of these mutants identi-
fied one, G411V, as exhibiting much greater stability
than the WT protein at elevated temperature, in a rela-
tively harsh detergent and during long-term storage at
both 20 and 4 °C [13]. It was this mutant that yielded
the high-resolution structure of the inward-facing con-
formation of UapA, although it should be noted that
an additional truncation of the first 11 amino acids
was required to yield well-diffracting crystals.
UapA seems to function via an elevator mechanism
[2], whereby the core or substrate-binding domain
[made up of transmembrane domain (TMs) 1, 2, 3, 4,
8, 9, 10 and 11] undergoes a translation and rotation
motion through the membrane, moving against the
gate or dimerisation domain (made up of TMs 5, 6, 7,
12, 13 and 14). The Val side chain in the G411V
mutant projects into the translocation channel, and it
is possible that the additional bulk of this residue,
compared with the WT Gly residue, prevents this
movement of the core domain from taking place, lock-
ing the protein in the inward-facing conformation.
UapA belongs to the SLC23 family of transporters
and is a structural homologue of the SLC4 and SLC26
transporters, all of which are suggested to also func-
tion via an elevator mechanism. Several of these have
been structurally characterised including the human
Anion Exchanger 1 protein [16], the human sodium-
coupled acid–base transporter, NBCe1 [17], the borate
transporter from Arabidopsis thaliana, AtBOR1 [18],
the cyanobacteria bicarbonate transporter [19] and the
prokaryotic fumarate transporter SLC26Dg [20]. Some
of these were artificially stabilised; for example, the
hAE1 and the SLC26Dg were crystallised as complexes
with antibody fragments or nanobodies. However, it is
unclear whether it is possible to stabilise proteins from
the SLC4 and SLC26 families using the equivalent
residue to G411V. A structure of a truncated version
of AtBOR1 is available but only at low resolution and
lacking almost all the loop regions. Thus, we
attempted to stabilise the AtBOR1 by introducing
mutations at positions Pro362 and Met363, both near
to the position of G411 of UapA. Our analysis indi-
cated that mutations at M363 had stabilising effects
on the protein, with M363F inducing the greatest sta-
bility, and demonstrated that stabilising mutations can
be transferred between structurally related proteins.
Materials and methods
Mutagenesis
All the mutants were generated using the QuikChange
Lightning Site-Directed Mutagenesis Kit (Agilent) using the
primers (Table S1) and the AtBOR1 WT gene as template.
Protein expression and membrane preparation
The WT AtBOR1 and the different mutants were individu-
ally expressed as fusions with a C-terminal tobacco etch
virus (TEV)-cleavable yEGFP His-tag in the pDDGFP-2
plasmid [21]. All the proteins were expressed as previously
described [21,22] in FGY217 Saccharomyces cerevisiae cells.
In brief, individual colonies were inoculated in 50 mL of -
URA media (2 gL1 amino acid mix w/o uracil, 6.7 gL1
yeast nitrogen base w/o amino acids) supplemented with
0.01% w/v glucose. The cells were cultured to an
OD600 = 0.6 at 30 °C and protein expression induced by
the addition of 2% galactose. The culture was incubated at
30 °C for 22 h with 300 r.p.m. shaking. The cells were har-
vested by centrifugation at 4000 g for 10 min at 4 °C and
then resuspended in the membrane resuspension buffer
(50 mM Tris/HCl pH 7.5, 1 mM EDTA and 0.6 M sorbitol
supplemented with 19 cOmplete EDTA-free protease inhi-
bitor cocktail tablet (Roche, Basel, Switzerland). The
expression level was assessed by measuring the fluorescence
signal of 200 µL cells in membrane resuspension buffer
using a SpectraMax M2e (Molecular Devices, San Jose,
CA, USA), with an excitation wavelength of 488 nm and
emission wavelength of 512 nm. Following the addition of
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500 µL of 0.5 mm glass beads, the cells were lysed using a
Biomedical MMP FastPrep-24 5G benchtop cell homogeni-
ser with six cycles of 20 s each followed by a 2-min incuba-
tion at 4 °C. The cell lysates were submitted to differential
centrifugation at 14 000 g for 30 s followed by 22 000 g
for 1 h at 4 °C. The resultant membrane pellets were resus-
pended in 900 µL of 20 mM Tris/HCl pH 7.5 and 0.3 M
sucrose. For large scale expression, protein was produced
in a total volume of 6 L of -URA media culture and the
cells lysed using a cell disruptor (Constant Systems, Daven-
try, Northants, UK) at 25, 30, 33 and 36 kpsi at 4 °C. Any
unbroken cells were separated by centrifugation at 10 000 g
for 10 min at 4 °C, with the membranes harvested by ultra-
centrifugation at 100 000 g for 2 h at 4 °C. The mem-
branes were resuspended in 6 mL of 20 mM Tris/HCl pH
7.5 and 0.3 M sucrose per litre of cell culture and either
used immediately or snap-frozen in liquid nitrogen and
stored at 80 °C until further use.
FSEC and hFSEC
Membranes containing the individual AtBOR1 constructs
were diluted in solubilisation buffer (19 PBS pH 7.5, 1%
w/v dodecyl b-D-maltoside (DDM) supplemented with 1
tablet of protease inhibitor) to a final protein concentration
of ~ 50 µgmL1. The samples were incubated for 1 h with
gentle mixing at 4 °C, followed by centrifugation at
14 000 g for 1 h at 4 °C to remove insoluble material. A
500 µL aliquot of the soluble supernatant was injected onto
a Superose 6 10/300 column equilibrated with 20 mM Tris/
HCl (pH 7.5), 150 mM NaCl and 0.03% DDM and the
fractions collected in 200 µL volume in a clear-bottomed
black 96-well microplate. The GFP fluorescence of the frac-
tions was measured using a SpectraMax M2e (Molecular
Devices) fluorimeter, with an excitation wavelength of
488 nm and emission wavelength of 512 nm. For heated
FSEC (hFSEC) experiments, the supernatant was incubated
at 46 °C for 10 min, centrifuged at 14 000 g for 10 min
and then loaded onto a Superose 6 10/300 column and
repeating the procedure as described above.
Localisation
Yeast cultures expressing the AtBOR1 constructs were cen-
trifuged briefly to harvest the cells which were then resus-
pended in 100 µL of 4% paraformaldehyde. After a 15-min
incubation at room temperature, the cells were washed
twice with 1 mL and then 20 µL of 1.2 M sorbitol, 16.6 mM
KH2PO4 and 83.4 mM K2HPO4. A 3–5 µL aliquot of the
fixed cells containing the different AtBOR1 constructs was
individually dispensed onto a microscope cover slide and
imaged on a Zeiss (Oberkochen, Germany) LSM-520-
inverted confocal microscope using a 639 oil immersion
lens.
Functional complementation assay
The different AtBOR1 constructs were individually trans-
formed into the FGY217 Δbor1p knockout S. cerevisiae
strain [23]. Transformants were inoculated in 10 mL of -
URA media supplemented with 2% w/v glucose and incu-
bated overnight at 30 °C, 300 r.p.m. After a fivefold serial
dilution with -URA media of the initial culture at
OD600 = 0.5, 10 µL of each dilution was spotted on -URA
plates containing 2% galactose supplemented with 0, 5 and
7.5 mM boric acid. The plates were then incubated at 30 °C
for 7 days and imaged with a ChemiDoc MP Imaging Sys-
tem (Bio-Rad, Hercules, CA, USA).
Isolation of mutant proteins
Membranes containing the mutant proteins, from a 6 L
expression volume, were solubilised for 1 h at 4 °C in solu-
bilisation buffer (19PBS pH 7.4, 100 mM NaCl, 10% v/v
glycerol, 1% w/v DDM) with a cOmplete EDTA-free pro-
tease inhibitor cocktail tablet (Roche). The insoluble mem-
branes were pelleted at 100 000 g for 45 min at 4 °C, and
the supernatant, supplemented with 10 mM imidazole, was
loaded onto 5 mL His-Trap pre-equilibrated with 19PBS
(pH7.4), 100 mM NaCl, 10% w/v glycerol and 0.03% v/v
DDM. After washing with increasing concentrations of imi-
dazole (20, 40, 60 mM), the protein was eluted with 1xPBS
(pH 7.4), 100 mM NaCl, 10% w/v glycerol, 0.03% v/v
DDM and 350 mM imidazole. The protein concentration in
the eluate was estimated via GFP fluorescence measure-
ment [21] and the sample was incubated (1 : 10 dilution) in
20 mM Tris/HCl (pH 7.5), 150 mM NaCl, 0.03% w/v DDM
for 16 h at 4 °C with His-tagged TEV protease (1 : 1
ratio). After a reverse-IMAC step in the His-Trap, the pro-
tein was eluted from a Superdex 200 10/300 column in
[20 mM Tris/HCl (pH 7.5), 150 mM NaCl and 0.03% w/v
DDM. The quality of the protein was assessed on a 12%
Tris-Glycine SDS/PAGE gel, and the central fractions were
pooled together and concentrated to 10 mgmL1 for crys-
tallisation trials.
Crystallisation and crystal harvesting
AtBOR1 M363F and AtBOR1 M363Y purified in the pres-
ence of 3 x CMC DDM or decyl b-D-maltoside (DM). A
variety of commercial screens (MemGold, MemGold2,
MemTrans; Molecular Dimensions, Sheffield, UK) were
employed to set up preliminary crystallisation trials by the
Mosquito crystallisation robot (SPT LabTech, Melbourn,
Herfordshire, UK) in sitting drop vapour diffusion (100 nL
protein + 100 nL crystallisation condition and 85 µL reser-
voir). AtBOR1 M363F in DM and DDM was also used to
set up crystallisation trials by hand (1 µL protein and 1 µL
condition, 850 µL reservoir) for optimisation of some con-
ditions identified from the commercial screens. Additive
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and detergent screens (Hampton Research, Aliso Viejo,
CA, USA) were also used with the following settings:
20 nL additive/detergent in the drop made of 100 nL pro-
tein and 100 nL crystallisation condition (9% PEG8000,
0.1 M MOPS pH 7), 85 µL reservoir. All buffers were
titrated with NaOH. The plates were stored at 4 and
20 °C. Crystals were shipped to Diamond Light Source,
Oxfordshire, UK, and screened on either i04 or the Micro-
focus beamline i24.
Results
P362 and M363 of AtBOR1 are possible
equivalent residues to G411 of UapA
A comparison of the UapA WT form (G411) with the
mutant that was structurally characterised (G411V)
illustrates the difference in bulk introduced by the Val
substitution at the interface between the gate (blue)
and core (red) domains (Fig. 1A,B). The structures of
AtBOR1 (PDB 5L25) and UapA-G411VD1-11 (PDB
56IC) were superposed using UCSF Chimera [24].
UapA-G411VD1-11 is in the inward-facing conforma-
tion while AtBOR1 is suggested to be in the inward
occluded conformation. The whole structures super-
pose with an RMSD of 13.8 A across all atom pairs
(Fig. 1C,D). This superposition suggested that either
P362 or M363 of AtBOR1 (Fig. 1E) was the struc-
turally equivalent residue to G411 of UapA. It was
difficult to be completely clear given the differences in
conformation of the two proteins. We chose to gener-
ate P362V and P362L mutants with a view to intro-
ducing a side chain that was bulkier than in the WT
protein. Given that M363 is already quite a bulky resi-
due, we substituted this with either a Phe or a Tyr.
AtBOR1 mutants express and traffic similarly to
WT
All the mutations expressed to a similar average level
as WT (typically ~ 3–4 mgL1) as assessed by GFP
fluorescence measurements (Fig. S1A). Both the WT
and mutant forms of the protein traffic to the mem-
brane as assessed by confocal microscopy (Fig. S1B).
Fig. 1. Identifying the equivalent residues to UapA G411V in AtBOR1 (A) Structure of UapA (PDB: 5I6C) in the inward-facing conformation
with the WT Gly residue at position 411. The core domain helices are coloured red, the gate domain helices are coloured blue with
interconnecting regions shown in grey. G411 is indicated in space-filling representation in pale pink, and the flanking residues, N410 and
V412 are shown in space-filling representation in grey. (B) Structure as in (A) but with the G411V substitution as obtained in the actual
structure of the protein. (C, D) Alignment of UapA and AtBOR1. The gate and core domains are coloured blue (UapA) and light blue
(AtBOR1), and the core domains are coloured red (UapA) and light pink (AtBOR1). V411 seen in the structure of UapA and possible
structurally equivalent residues P362 and M363 of AtBOR1 are shown in space-filling representation. C and D show the proteins from the
extracellular and intracellular sides of the membrane, respectively. (E) Structure of the AtBOR1 in the inward occluded state (PDB 5L25),
with P362 and M363 shown in space-filling representation in pale pink and grey, respectively. The core domain helices are coloured red and
the gate domain helices are coloured blue with interconnecting regions shown in grey. In all structure images, only a single monomer is
represented and TM3 and sections of the loop connecting TM3 and TM4 have been removed for clarity.
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AtBOR1 M363 mutants exhibit enhanced stability
compared with WT
FSEC and hFSEC analysis were used to obtain a Tm
for AtBOR1 solubilised in 1% DDM of 43 °C
(Fig. S2). This was then used as the basis for ther-
mostability analysis of the AtBOR1 mutants. All the
AtBOR1 constructs were expressed, solubilised in buf-
fer containing 1% DDM and then submitted to both
FSEC and hFSEC analysis. The solubilisation efficien-
cies were between 62 and 75% (Fig. S1C). All proteins
exhibited similar FSEC profiles to the WT (Fig. 2A,B,
left panels) with a good recovery of monodisperse sol-
uble protein. Following heating at the increased tem-
perature of 46 °C, there is a substantial loss of
monodisperse WT protein; however, both the M363F
and M363Y mutants exhibit at least 50% monodis-
perse protein. In all cases, at this higher temperature
there is a substantial increase in the aggregated pro-
tein, as shown by the first peak to be observed in the
SEC profile, the aggregation peak (Fig. 2A,B).
Analysis of the P362 mutants indicates that these are
no more stable than WT AtBOR1. The data clearly
indicate that the M363F and M363Y constructs are
more stable than both the P362 mutants and the WT
protein.
AtBOR1 M363 mutants show dramatically
reduced borate efflux activity
In order to assess the ability of the mutants to trans-
port borate, we used a S. cerevisiae Dbor1p knockout
strain which lacks the endogenous ScBOR1p.
ScBOR1p is responsible for efflux of borate from the
yeast cells. Without this protein, intracellular boron
builds up to toxic levels and inhibits yeast cell growth.
We individually transformed the WT AtBOR1 and dif-
ferent mutants into the Dbor1p strain and assessed cell
growth on solid media in the presence of different con-
centrations of boric acid. The Dbor1p strain (Fig. 3)
exhibits almost undetectable levels of growth at 5 and
Fig. 2. M363 mutants are more stable than WT The mutants and WT AtBOR1 were solubilised in 1% DDM and submitted directly to FSEC
(4 °C) or solubilised in 1% DDM and then heated at 46 °C for 10 min prior to centrifugation and column loading. The fluorescence for each
fraction was measured and the data normalised based on the maximum monodispersed peak (elutes ~ fraction 35) height obtained for the
WT. (A) The FSEC profiles obtained at 4 °C for the M363 mutants and WT or (B) the P362 mutants and WT (left panels) and following
heating at 46 °C (right panels). Data shown are representative of 3 independent experiments.
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7.5 mM boric acid. WT AtBOR1 functionally comple-
ments the knocked out ScBOR1p allowing effective
growth of the yeast cells at even 7.5 mM boric acid
(Fig. 3). The cells expressing the WT AtBOR1 show
better growth than our standard S. cerevisiae expres-
sion strain, FGY217, which endogenously expresses
ScBOR1p. This is probably the result of higher recom-
binant expression of the AtBOR1 compared with the
native expression levels of ScBOR1p. The P362V/L
mutants also effectively complement the loss of
ScBOR1p, resulting in yeast cell growth at all boric
acid concentrations tested and indicating that these
substitutions cause no or little loss in AtBOR1 func-
tion (Fig. S3). However, the cells transformed with
M363F and M363Y mutants exhibit markedly reduced
growth compared with the WT AtBOR1 (Fig. 3).
There appears to be some low-level borate efflux activ-
ity retained in these mutants as the cells expressing
these proteins did exhibit slightly better growth than
the Dbor1p strain at 5 and 7.5 mM boric acid (Fig. 3).
These data suggest that the M363F and M363Y
mutants function less effectively than either the WT
AtBOR1 or the P362 mutants. Given that the M363F/
Y mutants appear more stable than the WT protein
and exhibit substantially reduced transport activity, it
is possible that these variants may be preferentially in
a single conformation with very limited capacity to
undergo conformational rearrangements associated
with substrate transport.
M363F and M363Y yield more homogenous
protein and better diffracting crystals
All the data indicated that M363F and M363Y were
more stable than the WT and P362 mutants possibly
as a result of reduced conformational flexibility as
reported for the UapA-G411V. Thus, WT and both
M363 mutant proteins were submitted to large scale
expression and purification. It was possible to express
all the proteins in large scale and successfully isolate in
DDM-based buffer. All yielded highly monodisperse
size exclusion chromatography peaks (Fig. 4A,D,G)
although the protein samples appeared somewhat
heterogeneous on the SDS/PAGE gels (Fig. 4B,E,H).
The two prominent bands indicated on the gels corre-
spond to AtBOR1 as confirmed by mass spectrometry
analysis and therefore are likely to be monomer and
dimer forms of the protein. There are additional bands
just below the dimer and monomer bands. These are
possibly protein degradation products. Notably, these
are much less prominent in the case of both M363
mutants (Fig. 4E,H) compared with the WT protein
(Fig. 4B), supporting the fact that these are both more
stable than the WT protein. All proteins were submit-
ted to crystallisation trials and yielded crystals
(Fig. 4C,F,I) in several conditions. Needle-shaped
crystals of AtBOR1 M363F (~ 200 µm in length) were
obtained consistently in 0.1 M MOPS pH 7, 9%
PEG8000 in a 1 µL + 1 µL drop in a sitting drop
vapour diffusion set-up. These initial crystals were har-
vested, cryoprotected in 30% ethylene glycol and
screened at Diamond Light Source. None of the crys-
tals had a diffraction limit less than 10 A. Optimisa-
tion of the condition through the addition of 30% w/v
D-(+)-glucose monohydrate yielded rod-shaped crys-
tals, that were more 3-D and less fragile; typically,
~ 100µm in length (Fig. 4F Left). AtBOR1 M363F
was also purified in DM, and smaller (~ 80 µm) irreg-
ular shaped crystals were obtained in A10 MemGold2
(0.2 M Li sulphate, 0.1 M Na chloride, 0.1 M HEPES
Fig. 3. The M363 mutants exhibit reduced boron efflux activity. S. cerevisiae cells were spotted in a 59 series of dilution from left to right
on -URA media supplemented with 2% galactose and 0, 5, or 7.5 mM boric acid. Plates were incubated at 30 °C for 5 days before being
imaged. AtBOR1 M363F and M363Y were transformed in the S. cerevisiae knockout Dbor1p strain in order to assess the function of these
variants. The Dbor1p cells were also transformed with an empty vector as a negative control (Dbor1p in the figure) and FGY217 cells
expressing the endogenous ScBOR1p were used to demonstrate endogenous borate efflux (FGY217 in the figure). The Dbor1p cells
overexpressing AtBOR1 WT was also analysed as a positive control (WT in the figure).
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pH7, 31% v/v PEG400) (Fig. 4F Right). Crystals of
AtBOR1 M363Y in DDM were obtained in condition
E1 MemTrans (0.2 M Ammonium acetate, 0.1 M
sodium chloride, 0.1 M Bis-Tris pH 6.3, 12% PEG4000)
(Fig. 4I Left) and in C5 MemGold2 (0.1 M Magnesium
chloride hexahydrate, 0.1 M Tris pH 7.5, 13% w/v
PEG8000) when the mutant was purified in DM
(Fig. 4I Right). Although the maximal diffraction at
the moment is limited to ~ 5.5–6 A for AtBOR1
M363F in DDM, we observed a clear improvement in
the quality and diffraction limit of the crystals com-
pared with most of our WT AtBOR1 crystals (~ 7 A)
(Fig. 4C).
Discussion
Stabilisation by protein engineering remains one of the
key tools for obtaining membrane proteins in a
Fig. 4. Purification and crystallisation of AtBOR1 M363F and M363Y. Size exclusion chromatography profiles for WT (A), M363F (D) and
M363Y (G); V = retention volume (mL). SDS/PAGE analysis of the SEC elution fractions for WT (B), M363F (E) and M363Y (H). The bands
corresponding to monomeric (M) and dimeric protein (D) are indicated; kDa = molecular weight markers. (C) shows the WT crystals in 0.1 M
Tris pH 7.5, 0.1 M NaCl, 11% PEG4000, drop size 2 µL, scale bar = 1 mm. (F) Shows the crystals obtained for M363F purified in DDM and
grown in 9% PEG8000, 0.1 M MOPS pH 7, 30% w/v D-(+)-Glucose monohydrate, drop size 200 nL, scale bar = 500 µm (left), and M363F in
DM in 0.2 M Li sulphate, 0.1 M Na chloride, 0.1 M HEPES pH7, 31% v/v PEG400 (condition A10 MemGold2), drop size = 200 nL, scale
bar = 200 µm (right). (I) Crystals of M363Y in DDM in 0.2 M ammonium acetate, 0.1 M sodium chloride, 0.1 M Bis-Tris pH 6.3, 12% w/v
PEG4000 (E1 MemTrans), drop size 200 nL, s Scale bar = 500 µm (left), and of M363Y in DM in 0.1 M Magnesium chloride hexahydrate,
0.1 M Tris pH 7.5, 13% w/v PEG8000 (C5 MemGold2), drop size 200 µL, scale bar = 100 µm (right).
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suitable state for structural studies. However, when
working with a relatively large protein and limited
resources, it can be difficult to know where to start to
modify a given protein in order to produce a stable
construct. In this case, we attempted to map a stabilis-
ing mutant from UapA, an SLC23 family transporter,
to AtBOR1, an SLC4 family transporter. While these
proteins are from different transporter families and
share low overall sequence identity (16%), they do
share significant structural homology as illustrated in
Fig. 1. The two crystal structures available differ in
conformation with UapA in the inward-facing confor-
mation and the AtBOR1 in the inward occluded con-
formation. While the two proteins superimpose overall
relatively well, it was a little difficult to see which of
two residues of AtBOR1 (P362 and M363) might be
the direct structural equivalent of UapA G411V. Thus,
we decided to mutate both sites, increasing the bulk in
both cases substituting P362 to either Val or Leu and
substituting M363 to Phe or Tyr.
Mutations of P362 had no major effect on the sta-
bility of the protein, suggesting that either substitu-
tions at this site were not sufficiently bulky to block
the conformational rearrangements associated with the
elevator domain or that residue is in the wrong posi-
tion to affect that transition. A closer look at the most
likely conformation adopted by the substituted Val
and Leu residues suggests that P362V or P362L do not
project much further into the translocation channel
than the native, adjacent M363 residue (Fig. 5). How-
ever, substitution of the M363 residue with Phe or Tyr
results in a relatively longer side chain which might
prevent the movement of the core domain against the
gate domain (Fig. 5).
Both the M363F and M363Y proteins produce crys-
tallisable protein which in our hands consistently
results in more reproducible and slightly better
diffracting crystals than the WT. It is possible that
additional modifications need to be made in order to
increase the resolution further. In the case of UapA,
removal of a small section of the N terminus in addi-
tion to the G411V substitution was critical for success-
ful structure determination [11,13]. The available
structure of AtBOR1 was obtained of the protein lack-
ing the 59 C-terminal residues. In our hands, we have
found this construct to be less stable than the full-
length WT (data not shown); however, AtBOR1 does
contain a large intracellular loop (~ 100 residues)
between TMs 10 and 11. Removing this region or sta-
bilising it with a nanobody might facilitate high-
resolution X-ray crystallographic analysis. Alterna-
tively, our conformationally restricted mutants might
be suitable for cryo-EM analysis. Our AtBOR1 pro-
teins isolate as dimers in DDM [25], as seen in the
AtBOR1 structure, unlike the ScBOR1p [23]. While
the AtBOR1 dimer is still on the small side for cryo-
EM analysis, there are examples of proteins of similar
molecular weight that have been successfully struc-
turally characterised using this technique including the
SLC4 protein, NBCe1 [17].
Our study indicates that it is possible to identify sta-
bilising mutants of integral membrane transport pro-
teins based on structurally related molecules.
Mutagenesis is widely used as a means of stabilising pro-
teins; however, it potentially involves generating and
screening a large number of variants. We feel our results
show that it is at the very least worth attempting to
screen variants equivalent to those tried and tested in
other related proteins. Importantly, in our study, we
demonstrated that this approach may be successful
when the proteins are very distantly related. Our find-
ings should give researchers confidence that this
Fig. 5. Mutations at M363 have stabilising effects. (A) WT AtBOR1 from the structure (PDB 5L25). (B) AtBOR1 P362L and (C) AtBOR1
M363F. The mutations were generated in PyMol (Schr€odinger, New York, NY, USA) and the most likely position of the rotamer selected for
the image. Residues at position 362 and 363 are shown in pink and grey spheres, respectively. In all structure images, only a single
monomer is represented, the core domain helices are coloured red and the gate domain helices are coloured blue with interconnecting
regions shown in grey. TM3 and sections of the loop connecting TM3 and TM4 have been removed for clarity.
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approach represents one additional tool in the mem-
brane protein researcher’s toolbox. This may facilitate
structural studies of individual conformational states of
transporter proteins and also provide insights into con-
formational dynamics using emerging techniques for
membrane proteins such as hydrogen-deuterium
exchange-mass spectrometry (HDX-MS) [26].
Acknowledgements
This project has received funding from the European
Union’s Horizon 2020 research and innovation pro-
gramme, RAMP-ITN: Rationalising Membrane Pro-
tein Crystallisation Innovative Training Network,
under the Marie Sklodowska-Curie grant agreement
No 722687 (CC). This work was also supported by
Biotechnology and Biological Sciences Research Coun-
cil (BBSRC) grant BB/N016467/1 awarded to BB, AC
and AJ. The authors wish to acknowledge the Facility
for Imaging by Light Microscopy (FILM) at Imperial
College London is part-supported by funding obtained
from the Wellcome Trust (grant 104931/Z/14/Z) and
BBSRC (grant BB/L015129/1). We are also grateful to
Dr Marc Morgan and the Centre for Structural Biol-
ogy Crystallisation Facility for assistance in crystallisa-
tion and screening our crystals.
Conflict of interest
The authors declare no conflicts of interest.
Data Accessibility
All data relevant to the manuscript are presented in
the main manuscript or in the Supporting information.
Author contributions
BB and ADC conceived the project. CC and NJS gen-
erated and characterised the mutants. TCM and
ACMJ carried out some of the localisation experi-
ments. BB wrote the manuscript with input from all
other authors.
References
1 Jardetzky O (1966) Simple allosteric model for
membrane pumps. Nature 211, 969–970.
2 Drew D and Boudker O (2016) Shared molecular
mechanisms of membrane transporters. Annu Rev
Biochem 85, 543–572.
3 Abramson J, Smirnova I, Kasho V, Verner G, Kaback
HR and Iwata S (2003) Structure and mechanism of the
lactose permease of Escherichia coli. Science 301, 610–
615.
4 Errasti-Murugarren E, Fort J, Bartoccioni P, Dıaz L,
Pardon E, Carpena X, Espino-Guarch M, Zorzano A,
Ziegler C, Steyaert J et al. (2019) L amino acid
transporter structure and molecular bases for the
asymmetry of substrate interaction. Nat Commun 10,
1807–1812.
5 Coleman JA, Green EM and Gouaux E (2016) X-ray
structures and mechanism of the human serotonin
transporter. Nature 532, 334–339.
6 Coleman JA and Gouaux E (2018) Structural basis for
recognition of diverse antidepressants by the human
serotonin transporter. Nat Struct Mol Biol 25, 170–175.
7 Penmatsa A, Wang KH and Gouaux E (2013) X-ray
structure of dopamine transporter elucidates
antidepressant mechanism. Nature 503, 85–90.
8 Garaeva AA, Oostergetel GT, Gati C, Guskov A,
Paulino C and Slotboom DJ (2018) Cryo-EM structure
of the human neutral amino acid transporter ASCT2.
Nat Struct Mol Biol 25, 515–521.
9 Garaeva AA, Guskov A, Slotboom DJ and Paulino C
(2019) A one-gate elevator mechanism for the human
neutral amino acid transporter ASCT2. Nat Commun
10, 1–8.
10 Canul-Tec JC, Assal R, Cirri E, Legrand P, Brier S,
Chamot-Rooke J and Reyes N (2017) Structure and
allosteric inhibition of excitatory amino acid transporter
1. Nature 544, 446–451.
11 Alguel Y, Amillis S, Leung J, Lambrinidis G, Capaldi
S, Scull NJ, Craven G, Iwata S, Armstrong A, Mikros
E et al. (2016) Structure of eukaryotic purine/H(+)
symporter UapA suggests a role for homodimerization
in transport activity. Nat Commun 7, 11336–11339.
12 Leung J, Karachaliou M, Alves C, Diallinas G and
Byrne B (2010) Expression and purification of a
functional uric acid-xanthine transporter (UapA).
Protein Expr Purif 72, 139–146.
13 Leung J, Cameron AD, Diallinas G and Byrne B (2013)
Stabilizing the heterologously expressed uric acid-
xanthine transporter UapA from the lower eukaryote
Aspergillus nidulans. Mol Membr Biol 30, 32–42.
14 Koukaki M, Vlanti A, Goudela S, Pantazopoulou A,
Gioule H, Tournaviti S and Diallinas G (2005) The
nucleobase-ascorbate transporter (NAT) signature motif
in UapA defines the function of the purine
translocation pathway. J Mol Biol 350, 499–513.
15 Papageorgiou I, Gournas C, Vlanti A, Amillis S,
Pantazopoulou A and Diallinas G (2008) Specific
interdomain synergy in the UapA transporter
determines its unique specificity for uric acid among
NAT carriers. J Mol Biol 382, 1121–1135.
16 Arakawa T, Kobayashi-Yurugi T, Alguel Y, Iwanari H,
Hatae H, Iwata M, Abe Y, Hino T, Ikeda-Suno C,
Kuma H et al. (2015) Crystal structure of the anion
9FEBS Open Bio (2021) ª 2021 The Authors. FEBS Open Bio published by John Wiley & Sons Ltd on behalf of
Federation of European Biochemical Societies.
C. Cecchetti et al. Mutations of M363 stabilise A. thaliana BOR1
exchanger domain of human erythrocyte band 3.
Science 350, 680–684.
17 Huynh KW, Jiang J, Abuladze N, Tsirulnikov K, Kao
L, Shao X, Newman D, Azimov R, Pushkin A, Zhou
ZH et al. (2018) CryoEM structure of the human
SLC4A4 sodium-coupled acid-base transporter NBCe1.
Nat Commun 9, 900.
18 Thurtle-Schmidt BH and Stroud RM (2016) Structure
of Bor1 supports an elevator transport mechanism for
SLC4 anion exchangers. Proc Natl Acad Sci USA 113,
10542–10546.
19 Wang C, Sun B, Zhang X, Huang X, Zhang M, Guo H,
Chen X, Huang F, Chen T, Mi H et al. (2019) Structural
mechanism of the active bicarbonate transporter from
cyanobacteria. Nat Plants 5, 1184–1193.
20 Geertsma ER, Chang Y-N, Shaik FR, Neldner Y, Pardon
E, Steyaert J and Dutzler R (2015) Structure of a
prokaryotic fumarate transporter reveals the architecture
of the SLCfamily.Nature StrucMol Biol 22, 803–808.
21 Drew D, Newstead S, Sonoda Y, Kim H, von Heijne G
and Iwata S (2008) GFP-based optimization scheme for
the overexpression and purification of eukaryotic
membrane proteins in Saccharomyces cerevisiae. Nat
Protoc 3, 784–798.
22 Saouros S, Cecchetti C, Jones A, Cameron AD and
Byrne B (2020) Strategies for successful isolation of a
eukaryotic transporter. Protein Expr Purif 166, 105522.
23 Pyle E, Guo C, Hofmann T, Schmidt C, Ribiero O,
Politis A and Byrne B (2019) Protein-lipid interactions
stabilize the oligomeric state of BOR1p from
Saccharomyces cerevisiae. Anal Chem 91, 13071–13079.
24 Pettersen EF, Goddard TD, Huang CC, Couch GS,
Greenblatt DM, Meng EC and Ferrin TE (2004) UCSF
Chimera–a visualization system for exploratory research
and analysis. J Comput Chem 25, 1605–1612.
25 Bae HE, Cecchetti C, Du Y, Katsube S, Mortensen JS,
Huang W, Rehan S, Lee HJ, Loland CJ, Guan L et al.
(2020) Pendant-bearing glucose-neopentyl glycol (P-
GNG) amphiphiles for membrane protein
manipulation: Importance of detergent pendant chain
for protein stabilization. Acta Biomater 112, 250–261.
26 Martens C, Shekhar M, Borysik AJ, Lau AM, Reading E,
Tajkhorshid E, Booth PJ and Politis A (2018) Direct
protein-lipid interactions shape the conformational
landscape of secondary transporters. Nat Commun 9, 4151.
Supporting information
Additional supporting information may be found
online in the Supporting Information section at the end
of the article.
Table S1. Oligonucleotide pair sequences used for gen-
eration of the AtBOR1 mutants.
Fig. S1. Expression levels, solubilisation efficiencies
and localisation of WT and mutant forms of
AtBOR1. The expression levels (A), localisation (B)
and solubilisation efficiencies (C) of the individual
AtBOR1 constructs were assessed based on the fluo-
rescence of the fused GFP. The average expression
levels  SD of at least five independent experiments
are shown (A). Representative localisation images of
the individual proteins from 2 independent experi-
ments are shown (B). In each case a clear ring of
protein is evident corresponding to transporter cor-
rectly localised to the membrane. There are also
highly fluorescent punctate structures visible inside
the yeast cells likely to be the result of unfolded and
incorrectly trafficked protein. The images were gener-
ated using a 63X Oil Objective and analysed with Fiji
software. C) Solubilisation efficiencies were obtained
from at least 2 independent experiments for each
AtBOR1 mutant.
Fig. S2. Obtaining a Tm for WT AtBOR1. WT
AtBOR1 was expressed as a C-terminal GFP fusion
protein in S. cerevisiae as described in the main manu-
script, membranes were prepared and then solubilised
in 1% DDM. Individual aliquots (~ 20 µg/ sample)
were incubated at a range of temperatures (4, 25, 30,
35, 40, 45, 50 or 55 °C) prior to being loaded onto a
Superose 6 10/300 column. The individual fractions
were assessed for fluorescence indicating the presence
of GFP. The peak containing monodispersed fusion
protein is labelled M in panel A). The amount of
monodispersed protein reduces upon heating at tem-
peratures of 45 °C and above with an associated
increase in the amount of aggregated protein (peak
labelled A). The peak height was plotted against tem-
perature (B) and this indicated that the Tm for WT
AtBOR1 was ~ 43 °C.
Fig. S3. Functional complementation analysis of the
P362V and P363L mutants. S. cerevisiae cells were
spotted in a 59 series of dilution from left to right on
media containing 0, 5, or 7 mM boric acid. Plates were
incubated at 30 °C for 5 days before being imaged.
FGY217 Dbor1p cells were transformed with an empty
vector as a negative control (FGY217 Dbor1p).
FGY217 cells expressing the native ScBOR1p were
used to demonstrate endogenous BOR1p activity
(FGY217). FGY217 Dbor1p cells overexpressing
AtBOR1 WT were also analysed as a positive control.
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